Health

LBB Specialties and Imerys Form Specialty Distribution Partnership in North America

NORWALK, Conn., Sept. 16, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredient distribution inN...

2025-09-16 01:00 1429

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core probiotic strain CP-9 (Bifidobacterium lactis CCTCC M 2014588) has been approved with Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administr...

2025-09-15 22:00 1828

LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights

Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON CITY, Tenn. and HOUSTON, Sept. 15, 2025 /PRNewswire/ -- LabConnect, a leading global provider of central laboratory services today announced plans to ...

2025-09-15 21:03 1502

Kolmar Korea Advances 'Clean Beauty' with Breakthroughs from Eco-Friendly Packaging to R&D

* Sweeps global awards with eco-friendly packaging innovations, including paper tube, paper stick, and paper pack * Ranked No. 125 on TIME's "World's Best Companies for Sustainable Growth 2025," the only K-Beauty company on the list SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- Kolmar Ko...

2025-09-15 20:30 2982

SI GROUP TO SHOWCASE SUSTAINABLE ADDITIVE INNOVATIONS AT K 2025

Industry Leader Presents Advanced Solutions for Plastics and Rubber THE WOODLANDS, Texas, Sept. 15, 2025 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, will showcase its portfolio of ...

2025-09-15 20:30 1483

Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity

SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of RN3161 to the Australian Human Research Ethics Committee (HREC).RN3161 is a proprietary GalNAc-conjug...

2025-09-15 20:00 1575

FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient

MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals' patents covering technology relating to coffee fru...

2025-09-15 20:00 2423

Medit Link Express for iPad Debuts as Medit i900 Mobility Goes into Shipping

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- Medit (www.medit.com ), a global leader in digital dentistry, today announced two milestone moments for the industry. The company has officially launched Medit Link Express, its first iPad-native app ...

2025-09-15 19:00 1808

Clinically Proven Human Milk Probiotic LC40® supports Infant Health and Breastfeeding Mothers

SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and two safety trials,Kerry 's LC40® is the first probiotic strain of its kind validated for both infant and maternal applications, offering a natural, science-backed approach to early life and...

2025-09-15 18:20 1766

Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc

Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation. MELBOURNE, Australia, Sept. 15, 2025 /PRNewswi...

2025-09-15 12:06 1376

New Data, iCARE Study: Hailie® Smartinhaler® Powers Unprecedented Medication Adherence in Patients with COPD and Asthma

Highlights: * Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. * >60% patients achieved an average two-week baseline adherence with ~4 in 10 patients reaching the critical threshold...

2025-09-15 12:05 1758

MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics

SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for larg...

2025-09-15 11:53 1689

Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations

SINGAPORE and GUANGZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initi...

2025-09-15 08:00 1532

EverBridge Group and Cosmotec Forge Landmark Partnership

SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary of M3, Inc.; TSE: 2413) for the Japanese market. Jay Wang (Left) and Suguru Ominato ...

2025-09-15 08:00 2636

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium

* 7 new NEFECON® real-world evidence abstracts will be presented at the 18th  International lgA Nephropathy Symposium (IIgANN 2025). * The newly released results, based on clinical practices at several leading hospitals inChina, offer a comprehensive overview of the efficacy and safety of NEFE...

2025-09-15 07:45 4717

Senna Wellness Retreat introduces art showcase 'Trăng Lên Đỉnh Núi': A mid-autumn tribute to Kinh Bắc's beauty and community spirit

BAC NINH, Vietnam, Sept. 13, 2025 /PRNewswire/ -- From 12 to 21 September 2025, Senna Wellness Retreat presents the art showcase 'Trăng Lên Đỉnh Núi' to embrace its Mid-Autumn campaign's message of festive togetherness. Set against the breathtaking backdrop ofNorthern Vietnam, the showcase invite...

2025-09-13 16:35 4230

/C O R R E C T I O N -- Mars/

In the news release, Mars Snacking and Unreasonable Group Welcome Fourteen New Ventures to Unreasonable Food™, issued11-Sep-2025 by Mars over PR Newswire, we are advised by the company that the release has been updated to include the full 2025 Unreasonable Food cohort. The complete, corrected rel...

2025-09-13 06:14 5028

WFH mobilizes global community to achieve milestone revisions to WHO EML

MONTREAL, Sept. 12, 2025 /PRNewswire/ -- A concerted effort by the World Federation of Hemophilia (WFH) and its partners has led to the World Health Organization (WHO) updating its Essential Medicines List (EML) and the Essential Medicines List for Children (EMLc) to better align the EMLs to the ...

2025-09-12 21:42 1581

Pulnovo Medical Receives two IDE approvals for PADN system's clinical trials with CMS coverage

SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN catheter and generator has receivedtwo Investigational Device Exemption (IDE) approvals—HDE study ap...

2025-09-12 18:23 1862

3Shape Announces Leadership Transition: Rune Fisker Appointed External Executive Advisor to CEO After 25 Years of Pioneering Innovation

COPENHAGEN, Denmark, Sept. 12, 2025 /PRNewswire/ -- 3Shape today announced a leadership transition that honors one of its most influential innovators. After 25 years at the forefront of 3Shape's journey, Rune Fisker, Senior Vice President of Product Strategy, will step down from his current role ...

2025-09-12 15:47 2153
1 ... 30313233343536 ... 560